AstraZeneca has rejected Pfizer's final £55-per-share offer, saying it "falls short" of the Anglo-Swedish drugmaker's value as an independent company.
The decision sent shares in the Anglo-Swedish drugmaker down 14pc to £41.48 in early trading.
Pfizer late on Sunday returned to AstraZeneca for the fourth and final time with a sweetened offer.
more
{ 0 comments... » AstraZeneca rejects Pfizer's 'final' offer read them below or add one }
Post a Comment